Copeptin, a surrogate marker for arginine vasopressin secretion, is positively associated with glucagon
Diabetic Medicine Mar 20, 2019
Asferg CL, et al. - A sum of 102 healthy obese males and 27 healthy men of normal weight (control group) were analyzed to study the relationship between plasma copeptin (the C-terminal portion of provasopressin as well as a stable surrogate marker for arginine vasopressin secretion) with plasma glucagon in obese vs normal weighted candidates. They noted higher (median) plasma copeptin concentrations (6.6 vs 4.9 pmol/l) and mean ± sd plasma glucagon concentrations (8.5 ± 3.8 vs 5.3 ± 1.4 pmol/l) among obese cases when compared to the normal-weight men. A positive association of copeptin with glucagon was also reported. They suggested the probability of aggravating the hyperglucagonaemic state found in obese individuals due to an increase in arginine vasopressin secretion.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries